Total Funding
69
75
Total FundingConvertible Note raised
Growth Score 69 in past quarter
-3 pts
Heat Score 75 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
136433
Dymedso develops medical technologies to treat respiratory ailments
- Pierre Massicotte: Chief Financial Officer
- Laura McIntosh: Chief Executive Officer
About the Company
Founded in 2002 in Boisbriand, Québec, Dymedso employs ten people in the new medical technologies, providing assistance to patients suffering from chronic respiratory ailments. Dymedso has developed an acoustics technology for pulmonary physiotherapy. The company markets the Frequencer®, a non-invasive, no percussion technology used for respiratory
airways clearance with the use of low frequency sound acoustics.
